1Mona Lotfy Zamzam, 2Manal Mohamed Yassin and 3Maha Mohamed Sallam
Departments of 1Physical
Medicine and Rehabilitation, 2Microbiology
and Immunology and 3Biochemistry Faculty
of Medicine,
In a trial to throw light on the implication of intercellular
adhesion molecule-1 (ICAM-1) and NG-hydroxy- L- arginine (L-NHA) in the pathogenesis of systemic sclerosis or Scleroderma, (SSc), their serum
levels were estimated in twenty SSc patients using
ELISA and high performance liquid chromatography respectively. In situ
“local” expression of ICAM-1 in lesional skin of
these patients was also assessed using biotin- streptavidin
amplified detection system. Patients were divided into 3 groups according to
the cutaneous extension of sclerosis (Grades I; II & III). A significant (P<
0.001) difference was found between patients (n= 20)
and controls (n=10) regarding soluble ICAM-1 (s ICAM-1) and L- NHA levels.
Among patients, a significant difference (P< 0.001, 0.05
respectively) in sICAM-1 & L-NHA
serum levels was found between patients who had musculoskeletal manifestations
and those who had not. A significant (P< 0.001) difference in L-NHA level was found between patients with grade I, II, III.
Among patients, there was a negative correlation (r=
- 0.413) between serum sICAM-1 and the duration of
the disease, and a positive correlation (r= + 0.514)
between sICAM-1 and L-NHA
serum levels. 4 patients (23.6%) showed mild immunostaining,
8 patients (47%) showed moderate staining, and 5 patients (29.4%) showed
intense staining, while control specimens showed negative immunostaining.
In conclusion, ICAM-1 and serum L-NHA are probably
implicated in the pathogenesis of SSc. Elevated sICAM-1 and L-NHA serum could be
used as a quantitative marker of tissue sclerosis, allowing better follow up of
patients.